FDA Backs Medtronic Heart Device For Many More Patients

Law360, New York (April 10, 2012, 6:14 PM EDT) -- Federal regulators have given Medtronic Inc. their blessing to use a specialized implantable defibrillator for treatment of mild heart failure, potentially bringing the company’s technology to hundreds of thousands of new patients, Medtronic said Tuesday.

The company’s device, a cardioverter-defibrillator that uses resynchronization therapy, has been approved for more than a decade in patients with moderate to severe heart failure. The U.S. Food and Drug Administration is now permitting Medtronic’s use of the implant for mildly symptomatic heart failure patients. Boston Scientific Corp. received the same...
To view the full article, register now.